Immunogenicity of delayed TBE-vaccine booster

Vaccine

Volumn 30, Issue 3, 2012, Pages 499-502

  Askling, H H ^a,b   Vene, S ^c   Rombo, L ^a,d   Lindquist, L ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d Sormland County Council   (Sweden)

Author keywords

Booster dose; Neutralizing antibodies; TBE; Vaccination

Indexed keywords

FSME IMMUNE; NEUTRALIZING ANTIBODY; TICK BORNE ENCEPHALITIS VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; DRUG SAFETY; FEMALE; HUMAN; IMMUNOGENICITY; INJECTION SITE PAIN; INJECTION SITE REACTION; INJECTION SITE TENDERNESS; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT; VACCINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUSES, TICK-BORNE; ENCEPHALITIS, TICK-BORNE; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; MALE; MIDDLE AGED; VIRAL VACCINES; YOUNG ADULT;

EID: 84355166201     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.061     Document Type: Article

References (10)

1. Swedish Institute for Infectious Diseases Control. Available at: [accessed on 01.08.11]. http://www.smittskyddsinstitutet.se/statistik/viral-meningoencefalit/%3Ft=com%26p=17529%23statistics-nav.
2. Andersson C.R., Vene S., Insulander M., Lindquist L., Lundkvist A., Günther G. Vaccine failures after active immunisation against tick-borne encephalitis. Vaccine 2010, 28(April (16)):2827-2831.
3. Vene S., Haglund M., Lundkvist A., Lindquist L., Forsgren M. Study of the serological response after vaccination against tick-borne encephalitis in Sweden. Vaccine 2007, 25(January (2)):366-372.
4. Schosser R., Kaiser R., Mansmann U., Heininger U. Seropositivity before and seroprotection after a booster vaccination with FSME-Immun Adults in subjects with a time interval of ≥4.5 years since the last tick-borne encephalitis (TBE) vaccination. 10th International Jena symposium on tick-borne diseases 2009.
5. Heinz F.X., Holzmann H., Essl A., Kundi M. Field effectiveness of vaccination against tick-borne encephalitis. Vaccine 2007, 25(October (43)):7559-7567.
6. Weinberger B., Keller M., Fischer K.H., Stiasny K., Neuner C., Heinz F.X., et al. Decreased antibody titers and booster responses in tick-borne encephalitis vaccines aged 50-90 years. Vaccine 2010, 28(April (20)):3511-3515.
7. Hainz U., Jenewein B., Asch E., Pfeiffer K.P., Berger P., Grubeck-Loebenstein B. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 2005, 23(May (25)):3232-3235.
8. Rendi-Wagner P., Zent O., Jilg W., Plentz A., Beran J., Kollaritsch H. Persistence of antibodies after vaccination against tick-borne encephalitis. Int J Med Microbiol 2006, 296(Suppl. 40):202-207.
9. Jílková E., Vejvalková P., Stiborová I., Skorkovský J., Král V. Serological response to tick-borne encephalitis (TBE) vaccination in the elderly-results from an observational study. Expert Opin Biol Ther 2009, (7):797-803.
10. Bröker M., Schöndorf I. Are tick-borne encephalitis vaccines interchangeable?. Expert Rev Vaccines 2006, 5(August (4)):461-466.